Skip to content

PENG Block for Total Hip Arthroplasty

Periarticular Nerve Group (PENG) Block for Postoperative Rehabilitation in Total Hip Arthroplasty: a Randomized Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05944380
Enrollment
556
Registered
2023-07-13
Start date
2020-06-16
Completion date
2023-01-30
Last updated
2023-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Arthropathy, Hip Disease, Hip Osteoarthritis, Hip Pain Chronic

Keywords

periarticular nerve group block, total hip arthroplasty, pain management, multimodal analgesia, regional anesthesia

Brief summary

This randomized, double-blinded, placebo-controlled trial seeks to evaluate the efficacy of the pericapsular nerve group block on postoperative rehabilitation.

Detailed description

The pericapsular nerve group, or PENG block, has been recently described and shows promise in providing analgesia to the hip joint. However, the effect of this block on postoperative rehabilitation is uncertain. This study compares a preoperative PENG block to a placebo before total hip arthroplasty under spinal anesthesia. The primary outcome measure is verticalization, walking distance, ability to go out of bed, active lifting of the limb, range of motion in the hip joint, bending range of motion, and abduction range of motion. The secondary measure is postoperative pain assessment during rehabilitation.

Interventions

DRUGRopivacaine 0.5% Injectable Solution

20 mL 0.5% ropivacaine will be injected for the PENG block

DRUG0,9% normal saline

20 mL 0.9% normal saline will be injected for the PENG block

Sponsors

Poznan University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Intervention model description

randomized, double-blind, placebo-controlled

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients \> 18 years old undergoing unilateral total hip arthroplasty

Exclusion criteria

* refusal to participate * \< 18 yo * Chronic opioid use * localized infection

Design outcomes

Primary

MeasureTime frameDescription
postoperative Numeric Pain Rating Scale in motionDay 2Numeric Pain Rating Scale. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. no pain) to '10' representing the other pain extreme (e.g. pain as bad as you can imagine or worst pain imaginable)

Secondary

MeasureTime frameDescription
Time to first opioid96 hours postoperativelyHours to first administration of an intravenous opioid drug
postoperative Numeric Pain Rating Scale et restDay 1representing one pain extreme (e.g. no pain) to '10' representing the other pain extreme (e.g. pain as bad as you can imagine or worst pain imaginable)
Functional assessment: getting out of bed without helpFirst day after surgeryBinary assessment of motor function evaluated at the first day after surgical procedure
total opioid consumption96 hours postoperativelymilligrams of intravenous morphine equivalents
Functional assessment: independent verticalization- by the balconyFirst day after surgeryBinary assessment of motor function evaluated at the first day after surgical procedure
Functional assessment: walking by the balconyFirst day after surgeryBinary assessment of motor function evaluated at the first day after surgical procedure
Functional assessment: active elevation of the operated limbFirst day after surgeryBinary assessment of motor function evaluated at the first day after surgical procedure

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026